Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats

Free Radical Biology and Medicine

Volumn 44, Issue 9, 2008, Pages 1724-1731

  Fernández, Virginia ^a   Tapia, Gladys ^a   Varela, Patricia ^a   Gaete, Leonardo ^a   Vera, Gemma ^a   Mora, Catalina ^a   Vial, María T ^b   Videla, Luis A ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital FACH   (Chile)

Author keywords

Free radicals; Ischemia reperfusion injury; Liver preconditioning; N Acetylcysteine; Oxidative stress; Thyroid hormone

Indexed keywords

ACETYLCYSTEINE; ASPARTATE AMINOTRANSFERASE; CARBONYL DERIVATIVE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DNA BINDING; ENZYME INACTIVATION; ISCHEMIA; LIVER; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ANIMALS; ASPARTATE AMINOTRANSFERASES; GLUTATHIONE; ISCHEMIC PRECONDITIONING; LIVER; MALE; MODELS, BIOLOGICAL; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THYROID HORMONES; TRIIODOTHYRONINE;

ANIMALIA; RATTUS;

EID: 41549085661     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.01.010     Document Type: Article

References (47)

1. Jaeschke K. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol.: Gasterointest. Liver Physiol. 284 (2003) G15-G26
2. Carini R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003) 1480-1491
3. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-S44
4. Casillas-Ramírez A., Mosbah I.B., Ramalho F., Roselló-Catafau J., and Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 79 (2006) 1881-1894
5. Bertini R., Allegretti M., Bizzarri C., Moriconi A., Locati M., Zampella G., Cervellera M.N., Di Cioccio V., Cesta M.C., Galliera E., Martinez F.O., Di Bitondo R., Troiani G., Sabbatini V., D'Anniballe G., Anacardio R., Cutrin J.C., Cavalieri B., Mainiero F., Strippoli R., Villa P., Di Girolamo M., Martin F., Gentile M., Santoni A., Corda D., Poli G., Mantovani A., Ghezzi P., and Colotta F. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11791-11796
6. Terajima H., Enders G., Thiaener A., Hammer C., Kondo T., Thiery J., Yamamoto Y., Yamaoka Y., and Messmer K. Impact of hyperthermic preconditioning on postischemic hepatic microcirculation disturbances in an isolated perfusion model of rat liver. Hepatology 31 (2000) 407-415
7. Ito K., Ozaka H., Sanada K., and Horikawa S. Doxorubicin preconditioning: protection against rat hepatic ischemia-reperfusion injury. Hepatology 31 (2000) 416-419
8. Rüdiger H.A., Graf R., and Clavien P.A. Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J. Hepatol. 39 (2003) 972-977
9. Yu S.Y., Chiu J.H., Yang S.D., Yu H.Y., Hsied C.C., Chen P.J., Lui W.Y., and Wu C.W. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J. Surg. Res. 128 (2005) 28-36
10. Ajamieh H.H., Menendez S., Martínez-Sanchez G., Candelario-Jalil E., Re L., Giuliani A., and Fernández O.S. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 24 (2004) 55-62
11. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
12. Poli G., Leonarduzzi G., Biasi F., and Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 11 (2004) 1163-1182
13. Videla L.A., Fernández V., Tapia G., and Varela P. Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front. Biosci. 12 (2007) 1220-1228
14. Tapia G., Pepper I., Smok G., and Videla L.A. Kupffer cell function in thyroid hormone-induced liver oxidative stress. Free Radic. Res. 26 (1997) 267-279
15. Tapia G., Fernández V., Varela P., Cornejo P., Guerrero J., and Videla L.A. Thyroid hormone-induced oxidative stress triggers nuclear factor-kB activation and cytokine gene expression in rat liver. Free Radic. Biol. Med. 35 (2003) 257-265
16. Tran-Thi T.A., Decker K., and Baeuerle P.A. Differential activation of transcription factors NF-kB and AP-1 in rat liver macrophages. Hepatology 22 (1995) 613-619
17. Neuschwander-Tetri B.A., Bellezo J.M., Britton R.S., Bacon B.R., and Fox E.S. Thiol regulation of endotoxin-induced release of tumor necrosis factor a from isolated rat Kupffer cells. Biochem. J. 320 (1996) 1005-1010
18. Tsukamoto H. Redox regulation of cytokine expression in Kupffer cells. Antioxid. Redox Signal. 4 (2002) 741-748
19. Vrba J., and Modrianský M. Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed. Papers 146 (2002) 15-20
20. Fernández V., Tapia G., Varela P., and Videla L.A. Redox regulation of thyroid hormone-induced Kupffer cell-dependent IkB-a phosphorylation in relation to inducible nitric oxide synthase expression. Free Radic. Res. 39 (2005) 411-418
21. Fernández V., Tapia G., Varela P., Castillo I., Mora C., Moya F., Orellana M., and Videla L.A. Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of kB-a phosphorylation and nuclear factor-kB activation. J. Endocrinol. 186 (2005) 539-547
22. Tapia G., Fernández V., Pino C., Ardiles R., and Videla L.A. The acute-phase response of the liver in relation to thyroid hormone-induced redox signaling. Free Radic. Biol. Med. 40 (2006) 1628-1635
23. 3-induced hepatocyte proliferation in vivo. Biol. Chem. 388 (2007) 831-837
24. Fernández V., Castillo I., Tapia G., Romanque P., Uribe-Echevarría S., Uribe M., Cartier-Ugarte D., Santander G., Vial M.T., and Videla L.A. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology 45 (2007) 170-177
25. Moldeus P., and Cotgreave I.A. N-Acetylcysteine. Methods Enzymol. 234 (1994) 482-492
26. Jaworska M., Szulinska G., Wilk M., and Tautt J. Capillary electrophoretic separation of N-acetylcysteine and its impurities as a method for quality control of pharmaceuticals. J. Chromatogr. A 853 (1999) 479-485
27. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27 (1969) 287-290
28. Resnic A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
30. Deryckere F., and Gannon F.A. one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
31. Gloire G., Legrand-Poels S., and Piette J. NF-kB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006) 1493-1505
32. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
33. Takeuchi D., Yoshidome H., Kato A., Ito H., Kimura I., Shimizu M., Morita Y., and Miyazaki M. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 39 (2004) 699-710
34. Bradham C.A., Stachlewitz R.F., Gao W., Qian T., Jayadev S., Jenkins G., Hannun Y., Lemasters J.J., Thurman R.G., and Brenner D.A. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25 (1997) 1128-1135
35. Takahashi Y., Ganster R.W., Gambotto A., Shao L., Kaizu T., Wu T., Yagnik G.P., Nakao A., Tsoulfas G., Ishikawa T., Okuda T., Geller D.A., and Murase N. Role of NF-kB on liver cold ischemia-reperfusion injury. Am. J. Physiol.: Gasterointest. Liver Physiol. 283 (2001) G1175-G1184
36. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol. 18 (2000) 621-663
37. Hay R.T., Vuillard L., Desterro J.M.P., and Rodríguez M.S. Control of NF-kB transcriptional activation by signal induced proteolysis of IkBa. Philos. Trans. R. Soc. London 354 (1999) 1601-1609
38. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNF-a-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
39. Teoh N., Field J., Sutton J., and Farrell G. Dual role of tumor necrosis factor-a in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-a gene knockout mice. Hepatology 39 (2004) 412-421
40. Uehara T., Bennett B., Sakata S.T., Satoh Y., Bilter G.K., Westwick J.K., and Brenner D.A. JNK mediates hepatic ischemia reperfusion injury. J. Hepatol. 42 (2005) 850-859
41. Harada D., Naito S., Hiraoka I., and Otagiri M. In vivo kinetic analysis of covalent binding between N-acetyl-l-cysteine and plasma protein through the formation of mixed disulfide in rats. Pharm. Res. 19 (2002) 615-620
42. Yun C., Yan I., and Greene L.A. Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. J. Neurosci. 18 (1998) 4042-4049
43. Bergamini S., Rota C., Canali R., Staffieri M., Daneri F., Bini A., Giovannini B., Tomasi A., and Iannone A. N-Acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide: Biol. Chem. 5 (2001) 349-360
44. Zararullah M., Li W.Q., Sylvester J., and Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 60 (2003) 6-20
45. Clavien P.A., Yadav S., Sindram D., and Bentley R.C. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 232 (2000) 155-162
46. Totsuka E., Fung J.J., Urakami A., Moras N., Ishii T., Takehashi K., Narumi S., Nakamada K., and Sasaki M. Influence of donor cardiopulmonary arrest in human liver transplantation. Hepatology 31 (2000) 577-580
47. Brent G.A., and Larsen P.R. Treatment of hypothyroidism. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's The thyroid (1996), Lippincott-Raven, Philadelphia 883-887